Shubham Balasaheb Patil
About Shubham Balasaheb Patil
Data last updated:
Shubham Balasaheb Patil is a Director at Preciotech Industries Private Limited (since 2020) and Director at Flowsurge Healthcare Private Limited (since 2024). The companies operate in Equipment & Machinery. The largest current company by reported revenue is Preciotech Industries Private Limited at ₹24.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Preciotech Industries Private Limited U29100PN2020PTC195755 | Director | 06 Nov 2020 | 2020 | ₹24.2 Lakh (FY 2025) | Active |
| Flowsurge Healthcare Private Limited U32502PN2024PTC236472 | Director | 19 Dec 2024 | 2024 | Active |
Board colleagues of Shubham Balasaheb Patil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suraj Balaso Patil | 08951511 | Preciotech Industries Private Limited | Director |
| Ujawala Balasaheb Patil | 10878677 | Flowsurge Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shubham Balasaheb Patil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shubham Balasaheb Patil
Shubham Balasaheb Patil currently holds 2 directorships: Preciotech Industries Private Limited (Director, since 06 Nov 2020, revenue ₹24.2 Lakh (FY 2025)); Flowsurge Healthcare Private Limited (Director, since 19 Dec 2024).
Shubham Balasaheb Patil was first appointed on 06 Nov 2020 as Director at Preciotech Industries Private Limited. The most recent appointment on record is 19 Dec 2024 at Flowsurge Healthcare Private Limited.
The current boards of Shubham Balasaheb Patil's companies include Suraj Balaso Patil (Preciotech Industries Private Limited), Ujawala Balasaheb Patil (Flowsurge Healthcare Private Limited).